What are the earliest signs of metachromatic leukodystrophy that parents should watch for, especially in the late infantile form?::In the late infantile form, which is most common, parents might first notice a regression in motor skills that the child had already achieved, such as difficulty walking, frequent falls, or a change in gait. They may also observe muscle weakness, reduced responsiveness, or changes in speech. These symptoms typically appear around the second year of life and worsen over time.

re there any treatments available for metachromatic leukodystrophy, or ways to manage its progression?::While there is currently no cure for metachromatic leukodystrophy, treatments are available to manage symptoms and, in some cases, slow disease progression, especially if initiated early. These can include enzyme replacement therapy, gene therapy, and hematopoietic stem cell transplantation (HSCT) for specific forms and stages. Supportive care, such as physical therapy, occupational therapy, speech therapy, and medications for seizures or spasticity, is crucial to improve quality of life.

How is metachromatic leukodystrophy inherited, and what are the implications for other family members or future children?::Metachromatic leukodystrophy is an autosomal recessive disorder. This means a child must inherit two copies of the mutated gene (one from each parent) to develop the condition. Parents who each carry one copy of the mutated gene are typically unaffected but have a 25% chance with each pregnancy of having a child with the disorder. Genetic counseling and carrier testing are recommended for family members to understand their risk and options for family planning.

Metachromatic Leukodystrophy

Metachromatic leukodystrophy is a rare, inherited disorder characterized by the toxic accumulation of sulfatides, which progressively destroys the protective myelin sheath of the nervous system and leads to severe cognitive and motor decline.

Overview

Metachromatic leukodystrophy is an inherited disorder characterized by the accumulation of fats called sulfatides in cells. This accumulation especially affects cells in the nervous system that produce myelin, the substance that insulates and protects nerves. Nerve cells covered by myelin make up a tissue called white matter.

Sulfatide accumulation in myelin-producing cells causes progressive destruction of white matter (leukodystrophy) throughout the nervous system. This includes the brain and spinal cord (the central nervous system) as well as the nerves connecting the brain and spinal cord to muscles and sensory cells that detect sensations such as touch, pain, heat, and sound (the peripheral nervous system).

Symptoms & Progression

In people with metachromatic leukodystrophy, white matter damage causes progressive deterioration of intellectual functions and motor skills, such as the ability to walk. Affected individuals may develop:

Loss of sensation in the extremities (peripheral neuropathy)
Incontinence
Seizures
Paralysis
An inability to speak
Blindness and hearing loss
Loss of awareness of their surroundings and unresponsiveness

While neurological problems are the primary feature of this disorder, the effects of sulfatide accumulation on other organs and tissues have also been reported.

Forms of the Disorder

Metachromatic leukodystrophy is classified into three major forms based on the age of onset:

Late Infantile Form

This is the most common form of the disorder, affecting about 50 to 60 percent of all individuals with metachromatic leukodystrophy. It usually appears in the second year of life. Affected children lose any speech they have developed, become weak, and develop problems with walking (gait disturbance). As the disorder worsens, muscle tone generally decreases first, and then increases to the point of rigidity. Children with this form typically do not survive past childhood.

Juvenile Form

In 20 to 30 percent of individuals, onset occurs between the age of 4 and adolescence. The first signs of the juvenile form may be behavioral problems and increasing difficulty with schoolwork. Progression of the disorder is slower than in the late infantile form, and affected individuals may survive for about 20 years after diagnosis.

Adult Form

The adult form affects approximately 15 to 20 percent of individuals with the disorder, with symptoms appearing during the teenage years or later. Often, behavioral problems such as alcohol use disorder, drug abuse, or difficulties at school or work are the first symptoms to appear. Affected individuals may also experience psychiatric symptoms such as delusions or hallucinations. People with this form may survive for 20 to 30 years after diagnosis, experiencing periods of relative stability alongside periods of rapid decline.

Microscopic Appearance

The disorder gets its name from the way cells with accumulated sulfatides appear under a microscope. The sulfatides form granules described as metachromatic, meaning they pick up color differently than surrounding cellular material when stained for examination.

Frequency

Metachromatic leukodystrophy is reported to occur in 1 in 40,000 to 160,000 individuals worldwide. The condition is significantly more common in certain genetically isolated populations:

1 in 75 in a small group of Jews who immigrated to Israel from southern Arabia (Habbanites)
1 in 2,500 in the western portion of the Navajo Nation
1 in 8,000 among Arab groups in Israel

Causes

Most individuals with metachromatic leukodystrophy have mutations in the ARSA gene, which provides instructions for making the enzyme arylsulfatase A. This enzyme is located in cellular recycling centers called lysosomes, where it helps break down sulfatides.

A few individuals have mutations in the PSAP gene. This gene provides instructions for making a protein that is cleaved into smaller proteins that assist enzymes in breaking down fats. One of these smaller proteins, saposin B, works directly with arylsulfatase A to break down sulfatides.

Mutations in either the ARSA or PSAP gene result in a decreased ability to break down sulfatides, leading to their toxic accumulation in cells. This accumulation gradually destroys myelin-producing cells, impairing nervous system function.

In some cases, individuals with very low arylsulfatase A activity show no symptoms of the disorder. This harmless condition is called pseudoarylsulfatase deficiency.

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names for This Condition

ARSA deficiency
Arylsulfatase A deficiency disease
Cerebral sclerosis, diffuse, metachromatic form
Cerebroside sulphatase deficiency disease
Greenfield disease
Metachromatic leukoencephalopathy
MLD
Sulfatide lipidosis
Sulfatidosis